解剖学と生理学: 現在の研究
オープンアクセス

概要

Difficulties for Atrophic Age-RelatedMacular Degeneration Research

Suofu Qin

Age-related macular degeneration (AMD) is an idiopathic retinal degenerative malady that prevails in the old in the Western world as a reason for irreversible and significant vision misfortune [1,2]. AMD happens in two significant structures: atrophic (dry) AMD and exudative (wet)  AMD that are both piece of a similar infection cycle and offer comparative hazard factors. The atrophic AMD is described by RPE decay and subjacent photoreceptor degeneration and records for around 80~90% of AMD cases while the exudative AMD is portrayed by choroidal neovascularization (CNV) and retinal discharge . Photodynamic treatment, medical procedure, and hostile to VEGF treatment are as of now accessible medicines for AMD patients with CNV. Notwithstanding, no treatment is accessible yet for keeping up or improving vision related with atrophic AMD since creating pharmacological methodologies to forestall beginning or movement of atrophic AMD faces noteworthy